Zynerba Pharmaceuticals, Inc. Current Ratio 2015-2023 | ZYNE
Zynerba Pharmaceuticals, Inc. current ratio from 2015 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-06-30 | $0.04B | $0.01B | 3.43 |
| 2023-03-31 | $0.05B | $0.01B | 4.95 |
| 2022-12-31 | $0.06B | $0.01B | 5.97 |
| 2022-09-30 | $0.06B | $0.01B | 6.45 |
| 2022-06-30 | $0.07B | $0.01B | 6.89 |
| 2022-03-31 | $0.07B | $0.01B | 8.21 |
| 2021-12-31 | $0.08B | $0.01B | 8.10 |
| 2021-09-30 | $0.09B | $0.01B | 8.08 |
| 2021-06-30 | $0.10B | $0.01B | 9.62 |
| 2021-03-31 | $0.11B | $0.01B | 8.53 |
| 2020-12-31 | $0.07B | $0.01B | 5.27 |
| 2020-09-30 | $0.08B | $0.01B | 7.08 |
| 2020-06-30 | $0.09B | $0.01B | 6.54 |
| 2020-03-31 | $0.08B | $0.01B | 7.31 |
| 2019-12-31 | $0.09B | $0.01B | 7.22 |
| 2019-09-30 | $0.09B | $0.01B | 10.08 |
| 2019-06-30 | $0.09B | $0.01B | 9.37 |
| 2019-03-31 | $0.07B | $0.01B | 9.94 |
| 2018-12-31 | $0.07B | $0.01B | 6.88 |
| 2018-09-30 | $0.07B | $0.01B | 7.95 |
| 2018-06-30 | $0.05B | $0.01B | 4.34 |
| 2018-03-31 | $0.06B | $0.01B | 6.51 |
| 2017-12-31 | $0.07B | $0.01B | 9.17 |
| 2017-09-30 | $0.07B | $0.01B | 8.65 |
| 2017-06-30 | $0.08B | $0.01B | 9.72 |
| 2017-03-31 | $0.08B | $0.01B | 12.01 |
| 2016-12-31 | $0.04B | $0.01B | 5.23 |
| 2016-09-30 | $0.04B | $0.01B | 7.18 |
| 2016-06-30 | $0.04B | $0.01B | 7.07 |
| 2016-03-31 | $0.04B | $0.00B | 13.22 |
| 2015-12-31 | $0.04B | $0.00B | 11.03 |
| 2015-09-30 | $0.05B | $0.00B | 17.27 |
| 2015-06-30 | $0.01B | $0.00B | 2.27 |
| 2015-03-31 | $0.01B | $0.00B | 3.08 |
| 2014-12-31 | $0.01B | $0.00B | 3.69 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
